Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Joseph P. Horrigan"'
Autor:
Melissa Kennedy, Larry Glass, Daniel G. Glaze, Steve Kaminsky, Alan K. Percy, Jeffrey L. Neul, Nancy E. Jones, Daniela Tropea, Joseph P. Horrigan, Paige Nues, Kathie M. Bishop, James M. Youakim
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2024)
Rett syndrome (RTT) is rare neurodevelopmental disorder caused by mutations in the MECP2 gene that encodes methyl-CpG-binding protein 2 (MeCP2), a DNA-binding protein with roles in epigenetic regulation of gene expression. Functional loss of MeCP2 re
Externí odkaz:
https://doaj.org/article/b550d1b8d2c644c1ba103860350a3bb0
Autor:
Sean Oosterholt, Oscar Della Pasqua, Tiago Gomes, Stuart Evans, Mike Snape, Hanns Lochmüller, Nikoletta Nikolenko, Joseph P. Horrigan, Alison McMorn, Alex Yaroshinsky
Publikováno v:
Pediatric Neurology. 112:84-93
GSK3β is an intracellular regulatory kinase that is dysregulated in multiple tissues in type 1 myotonic dystrophy, a rare neuromuscular disorder that manifests at any age. AMO-02 (tideglusib) inhibits GSK3β activity in preclinical models of type 1
Autor:
Elizabeth Berry-Kravis, Joseph P. Horrigan, Nicole Tartaglia, Randi Hagerman, Alexander Kolevzon, Craig A. Erickson, Shivkumar Hatti, Mike Snape, Alex Yaroshinsky, George Stoms, Larry Glass, Nancy E. Jones, Kevin Sanders, Jean Frazier, Thomas Challman, Jeffrey Innis, Bryan King, Joseph Cubells, Jeannie Visootsak, Steven Skinner, Dianne Treadwell-Deering, Sherry Sellers Vinson, Howard Needelman
Publikováno v:
Pediatric neurology. 110
We analyze the safety and tolerability of trofinetide and provide a preliminary evaluation of its efficacy in adolescent and adult males with fragile X syndrome.This study was an exploratory, phase 2, multicenter, double-blind, placebo-controlled, pa
Autor:
Amber Salter, Joseph P. Horrigan, Jane B. Lane, Daniel G. Glaze, Steve A. Skinner, Walter E. Kaufmann, Nancy E. Jones, Alan K. Percy, Gary Cutter, Jeffrey L. Neul
Publikováno v:
Journal of Autism and Developmental Disorders. 47:1102-1112
Rett syndrome (RTT) requires total caregiver attention and leads to potential difficulties throughout life. The Caregiver Burden Inventory, designed for Alzheimer disease, was modified to a RTT Caregiver Inventory Assessment (RTT CIA). Reliability an
Autor:
Nicole Heilbron, Geraldine Dawson, Barbara Waters-Pick, Linmarie Sikich, Maura Sabatos-DeVito, Saritha Vermeer, Allen W. Song, J.H. Baker, Michael Andrew Murias, Kristin Page, Joanne Kurtzberg, Vinod K. Prasad, Samantha Major, Jesse D. Troy, Fred Sanfilippo, Kimberly L. H. Carpenter, Scott N. Compton, Megan Deaver, Jill Howard, Andrzej S. Kosinski, Jessica Sun, Brianna Herold, Joseph P. Horrigan, Ryan A. Simmons, Lauren Franz
Publikováno v:
The Journal of Pediatrics. 222:164-173.e5
Objective To evaluate whether umbilical cord blood (CB) infusion is safe and associated with improved social and communication abilities in children with autism spectrum disorder (ASD). Study design This prospective, randomized, placebo-controlled, d
Autor:
Matcheri S. Keshavan, L. Fredrik Jarskog, Cameron S. Carter, Margaret A. Peykamian, Michael F. Green, Larry J. Seidman, Alan Breier, Martin T. Lowy, John G. Csernansky, Jeffrey A. Lieberman, Joshua T. Kantrowitz, Donald C. Goff, Stephen R. Marder, Richard S.E. Keefe, M. Patricia Ball, Robert P. McMahon, Joseph P. Horrigan, Robert W. Buchanan, Marc Laurelle, Paul Maruff, Richard Grove
Publikováno v:
Schizophrenia Research. 164:136-142
This Phase II exploratory study assessed GSK239512, a brain penetrant histamine H₃ receptor antagonist, versus placebo on cognitive impairment in 50 stable outpatients with schizophrenia. Subjects were randomized to placebo or GSK239512 for 7 weeks
Autor:
Bernhard Suter, Nancy E. Jones, Jeffrey L. Neul, Joseph P. Horrigan, Thuy Dinh, Arthur A. Beisang, Mike Snape, Alan K. Percy, Evdokia Anagnostou, Daniel G. Glaze, Timothy Feyma
Publikováno v:
Journal of child neurology, vol 30, iss 13
Rett syndrome is a genetically based neurodevelopmental disorder. Although the clinical consequences of Rett syndrome are profound and lifelong, currently no approved drug treatments are available specifically targeted to Rett symptoms. High quality
Autor:
Joseph P. Horrigan, Marisela Huerta, Alycia K. Halladay, Lawrence Scahill, Evdokia Anagnostou, Katherine J. Sullivan, Paul P. Wang, Catherine Lord, Nancy E. Jones, Connie Kasari, Dennis W. Choi, Geraldine Dawson
Publikováno v:
Autism. 19:622-636
Social communication impairments are a core deficit in autism spectrum disorder. Social communication deficit is also an early indicator of autism spectrum disorder and a factor in long-term outcomes. Thus, this symptom domain represents a critical t
Autor:
Andrew P Nicholls, Andreas Mahler, Pradeep J. Nathan, Conn M Harrington, Rebecca L. Boardley, Paul Maruff, Alienor Berges, Joseph P. Horrigan, Richard Grove, Martin T. Lowy, Isabel Jm Beresford
Publikováno v:
Current Alzheimer Research. 11:47-58
Introduction: Histaminergic H 3 receptors may play a role in modulating cholinergic and monoaminergic neurotransmission. This Phase II study evaluated the efficacy and safety of GSK239512, a highly potent, brain penetrant H 3 receptor antagonist as m
Autor:
S. Pirruccello, S. Shackelford, Ole Graff, Sieghart Sopper, Richard Grove, M. Gold, Eva Havrdova, Joseph P. Horrigan
Publikováno v:
European Journal of Neurology. 20:1032-1042
Background and purpose Firategrast is an orally bioavailable alpha4 beta1/alpha4 beta7 integrin antagonist designed to reduce trafficking of lymphocytes into the central nervous system (CNS). This could decrease multiple sclerosis (MS) activity, but